Type I | ALK1 (ACVRL1) |
- Kinase inhibitors: K-02288
- ML-347 (LDN-193719, VU0469381)
- Other inhibitors: Disitertide
|
---|
ALK2 (ACVR1A) |
- Kinase inhibitors: DMH-1
- DMH-2
- Dorsomorphin (BML-275)
- K-02288
- ML-347 (LDN-193719, VU0469381)
|
---|
ALK3 (BMPR1A) |
- Kinase inhibitors: DMH-2
- Dorsomorphin (BML-275)
- K-02288
|
---|
ALK4 (ACVR1B) |
- Kinase inhibitors: A 83-01
- SB-431542
- SB-505124
|
---|
ALK5 (TGFβR1) | |
---|
ALK6 (BMPR1B) |
- Agonists: BMP (2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B))
- Dibotermin alfa
- Eptotermin alfa
- GDF (5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 15)
- Radotermin
- Kinase inhibitors: DMH-2
- Dorsomorphin (BML-275)
- K-02288
|
---|
ALK7 (ACVR1C) |
- Kinase inhibitors: A 83-01
- SB-431542
- SB-505124
|
---|
|
---|
Type II | TGFβR2 |
- Kinase inhibitors: DMH-2
- LY-364947
|
---|
BMPR2 | |
---|
ACVR2A (ACVR2) |
- Agonists: Activin (A, B, AB)
- BMP (2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B))
- Dibotermin alfa
- Eptotermin alfa
- GDF (1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 11 (BMP11), 15)
- Myostatin (GDF8)
- Nodal
- Radotermin
|
---|
ACVR2B |
- Agonists: Activin (A, B, AB)
- BMP (2, 4, 6, 7)
- Dibotermin alfa
- Eptotermin alfa
- GDF (1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12))
- Myostatin (GDF8)
- Nodal
- Osteogenin (BMP3, BMP3A)
- Radotermin
- Decoy receptors: Ramatercept
|
---|
AMHR2 (AMHR) | |
---|
|
---|